In 2021, the WHO (World Health Organization) updated the classification method for gliomas by combining histological diagnosis with molecular variations such as IDH and H3 G34 mutation status and co-deletion of the short arm of chromosome 1 and the long arm of chromosome 19 (1p/19q codeletion)2. The gene discussed is IDH1; the disease is central nervous system cancer.